Kopin (KOPN) 10-Q 6 Aug 20 2020 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 27, 2020	Aug. 04, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 27, 2020
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2020
Current Fiscal Year End Date	--12-26
Entity File Number	0-19882
Entity Registrant Name	KOPIN CORPORATION
Entity Central Index Key	0000771266
Entity Tax Identification Number	04-2833935
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	125 North Drive
Entity Address, City or Town	Westborough
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01581-3335
City Area Code	(508)
Local Phone Number	870-5959
Title of 12(b) Security	Common Stock, par value $0.01
Trading Symbol	KOPN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		84,963,042

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 27, 2020	Dec. 28, 2019
Current assets:
Cash and equivalents	$ 8,776,820	$ 6,029,247
Marketable debt securities, at fair value	6,485,696	15,752,997
Accounts receivable, net of allowance of $427,000 in 2020 and $938,000 in 2019	6,682,329	6,023,250
Contract assets and unbilled receivables	2,509,258	921,082
Inventory	3,712,047	3,768,696
Prepaid taxes	98,137	104,442
Prepaid expenses and other current assets	1,298,914	1,164,927
Total current assets	29,563,201	33,764,641
Property, plant and equipment, net	1,328,207	1,473,341
Operating lease right-of-use assets	2,260,319	2,753,963
Other assets	253,750	517,411
Equity investments	4,222,896	4,537,159
Total assets	37,628,373	43,046,515
Current liabilities:
Accounts payable	3,068,657	3,998,234
Accrued payroll and expenses	1,630,783	2,203,773
Accrued warranty	508,000	509,000
Contract liabilities and billings in excess of revenues earned	1,687,403	796,794
Operating lease liabilities	1,077,756	1,041,695
Other accrued liabilities	1,891,756	2,202,217
Customer deposits	608,386	33,000
Taxes payable	506,000	525,000
Total current liabilities	10,978,741	11,309,713
Noncurrent contract liabilities and asset retirement obligations	248,384	268,440
Operating lease liabilities, net of current portion	1,236,818	1,791,590
Other long-term obligations	1,104,514	1,085,160
Stockholders’ equity:
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued
Common stock, par value $.01 per share: authorized, 120,000,000 shares; issued 89,483,546 shares in 2020 and 88,912,796 shares in 2019; outstanding 82,596,416 in 2020 and 82,536,416 in 2019, respectively	871,096	870,496
Additional paid-in capital	344,776,079	344,456,537
Treasury stock (4,513,256 shares in 2020 and 2019, at cost)	(17,238,669)	(17,238,669)
Accumulated other comprehensive income	1,705,520	1,757,184
Accumulated deficit	(305,953,973)	(301,236,913)
Total Kopin Corporation stockholders’ equity	24,160,053	28,608,635
Noncontrolling interest	(100,137)	(17,023)
Total Kopin Corporation stockholders’ equity	24,059,916	28,591,612
Total liabilities and stockholders’ equity	$ 37,628,373	$ 43,046,515

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Jun. 27, 2020	Dec. 28, 2019
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 427,000	$ 938,000
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	3,000	3,000
Preferred stock, shares issued	0	0
Common Stock, Par or Stated Value Per Share		$ 0.01
Common Stock, Shares Authorized		120,000,000
Common Stock, Shares, Issued	89,483,546	88,912,796
Common Stock, Shares, Outstanding	82,596,416	82,536,416
Treasury stock, shares	4,513,256	4,513,256

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Revenues:
Total revenues	$ 8,814,646	$ 9,110,133	$ 16,693,251	$ 14,653,058
Expenses:
Cost of product revenues	4,779,577	5,242,514	10,427,424	11,119,591
Research and development	2,221,154	3,330,202	4,560,902	8,296,918
Selling, general and administration	2,909,366	5,375,671	6,341,457	11,658,474
Total expenses	9,910,097	13,948,387	21,329,783	31,074,983
Loss from operations	(1,095,451)	(4,838,254)	(4,636,532)	(16,421,925)
Other income:
Interest income	34,030	154,310	107,436	317,671
Other expense, net	(49,757)	(111,472)	(37,080)	(221,207)
Foreign currency transaction gains (losses)	9,995	(183,608)	(162,998)	52,527
Gain on investments		768,000		768,000
Total other income and expense	(5,732)	627,230	(92,642)	916,991
Loss before provision for income taxes and net loss (income) attributable to noncontrolling interest	(1,101,183)	(4,211,024)	(4,729,174)	(15,504,934)
Tax provision	(42,000)	(26,000)	(71,000)	(52,000)
Net loss	(1,143,183)	(4,237,024)	(4,800,174)	(15,556,934)
Net loss (income) attributable to the noncontrolling interest	21,642	(23,367)	83,114	(34,384)
Net loss attributable to Kopin Corporation	$ (1,121,541)	$ (4,260,391)	$ (4,717,060)	$ (15,591,318)
Net loss per share
Basic and diluted	$ (0.01)	$ (0.05)	$ (0.06)	$ (0.20)
Weighted average number of common shares outstanding
Basic and diluted	82,569,379	81,950,352	82,552,896	78,459,666
Net Product Revenues [Member]
Revenues:
Total revenues	$ 6,670,303	$ 4,435,401	$ 12,589,509	$ 9,049,257
Research and Development and Other Revenues [Member]
Revenues:
Total revenues	$ 2,144,343	$ 4,674,732	$ 4,103,742	$ 5,603,801

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Income Statement [Abstract]
Net loss	$ (1,143,183)	$ (4,237,024)	$ (4,800,174)	$ (15,556,934)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(37,035)	121,026	152,043	(1,038)
Unrealized holding gain (loss) on marketable securities	95,683	104,257	(182,679)	326,257
Reclassification of holding losses in net loss	(11,680)	(4,815)	(21,028)	(7,434)
Other comprehensive income (loss), net of tax	46,968	220,468	(51,664)	317,785
Comprehensive loss	(1,096,215)	(4,016,556)	(4,851,838)	(15,239,149)
Comprehensive loss (income) attributable to the noncontrolling interest	21,642	(23,367)	83,114	(34,384)
Comprehensive loss attributable to Kopin Corporation	$ (1,074,573)	$ (4,039,923)	$ (4,768,724)	$ (15,273,533)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total Kopin Corporation Stockholders Equity [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 29, 2018	$ 785,220	$ 334,491,397	$ (17,238,669)	$ 1,554,587	$ (271,730,661)	$ 47,861,874	$ (149,053)	$ 47,712,821
Balance, shares at Dec. 29, 2018	78,522,066
Stock-based compensation expense		815,842				815,842		815,842
Vesting of restricted stock	$ 100	(100)
Vesting of restricted stock, shares	10,000
Repurchases of restricted stock to satisfy tax withholding obligations	$ (43)	(7,085)				(7,128)		(7,128)
Repurchases of restricted stock to satisfy tax withholding obligations, shares	(4,294)
Other comprehensive loss				97,317		97,317		97,317
Sale of registered stock	$ 72,727	7,237,273				7,310,000		7,310,000
Sale of registered stock, shares	7,272,727
Net (loss) income					(11,330,927)	(11,330,927)	11,017	(11,319,910)
Ending balance, value at Mar. 30, 2019	$ 858,004	342,537,327	(17,238,669)	1,651,904	(283,061,588)	44,746,978	(138,036)	44,608,942
Balance, shares at Mar. 30, 2019	85,800,499
Beginning balance, value at Dec. 29, 2018	$ 785,220	334,491,397	(17,238,669)	1,554,587	(271,730,661)	47,861,874	(149,053)	47,712,821
Balance, shares at Dec. 29, 2018	78,522,066
Other comprehensive loss								317,785
Net (loss) income								(15,556,934)
Ending balance, value at Jun. 29, 2019	$ 865,669	343,796,667	(17,238,669)	1,872,372	(287,321,979)	41,974,060	(114,669)	41,859,391
Balance, shares at Jun. 29, 2019	86,566,953
Beginning balance, value at Mar. 30, 2019	$ 858,004	342,537,327	(17,238,669)	1,651,904	(283,061,588)	44,746,978	(138,036)	44,608,942
Balance, shares at Mar. 30, 2019	85,800,499
Stock-based compensation expense		538,474				538,474		538,474
Vesting of restricted stock	$ 600	(600)
Vesting of restricted stock, shares	60,000
Other comprehensive loss				220,468		220,468		220,468
Sale of registered stock	$ 7,065	721,466				728,531		728,531
Sale of registered stock, shares	706,454
Net (loss) income					(4,260,391)	(4,260,391)	23,367	(4,237,024)
Ending balance, value at Jun. 29, 2019	$ 865,669	343,796,667	(17,238,669)	1,872,372	(287,321,979)	41,974,060	(114,669)	41,859,391
Balance, shares at Jun. 29, 2019	86,566,953
Beginning balance, value at Dec. 28, 2019	$ 870,496	344,456,537	(17,238,669)	1,757,184	(301,236,913)	28,608,635	(17,023)	28,591,612
Balance, shares at Dec. 28, 2019	87,049,672
Stock-based compensation expense		158,465				158,465		158,465
Other comprehensive loss				(98,632)		(98,632)		(98,632)
Net (loss) income					(3,595,519)	(3,595,519)	(61,472)	(3,656,991)
Ending balance, value at Mar. 28, 2020	$ 870,496	344,615,002	(17,238,669)	1,658,552	(304,832,432)	25,072,949	(78,495)	24,994,454
Balance, shares at Mar. 28, 2020	87,049,672
Beginning balance, value at Dec. 28, 2019	$ 870,496	344,456,537	(17,238,669)	1,757,184	(301,236,913)	28,608,635	(17,023)	28,591,612
Balance, shares at Dec. 28, 2019	87,049,672
Other comprehensive loss								(51,664)
Net (loss) income								(4,800,174)
Ending balance, value at Jun. 27, 2020	$ 871,096	344,776,079	(17,238,669)	1,705,520	(305,953,973)	24,160,053	(100,137)	24,059,916
Balance, shares at Jun. 27, 2020	87,109,672
Beginning balance, value at Mar. 28, 2020	$ 870,496	344,615,002	(17,238,669)	1,658,552	(304,832,432)	25,072,949	(78,495)	24,994,454
Balance, shares at Mar. 28, 2020	87,049,672
Stock-based compensation expense		161,677				161,677		161,677
Vesting of restricted stock	$ 600	(600)
Vesting of restricted stock, shares	60,000
Other comprehensive loss				46,968		46,968		46,968
Net (loss) income					(1,121,541)	(1,121,541)	(21,642)	(1,143,183)
Ending balance, value at Jun. 27, 2020	$ 871,096	$ 344,776,079	$ (17,238,669)	$ 1,705,520	$ (305,953,973)	$ 24,160,053	$ (100,137)	$ 24,059,916
Balance, shares at Jun. 27, 2020	87,109,672

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019
Cash flows from operating activities:
Net loss	$ (4,800,174)	$ (15,556,934)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	341,743	438,294
Accretion of premium or discount on marketable debt securities	4,400
Recovery of impairment on marketable debt securities	(150,644)
Stock-based compensation	320,142	1,354,316
Foreign currency losses (gains)	186,516	(73,231)
Change in allowance for bad debt	(504,432)	330,172
Write-off of excess inventory	924,679	2,406,492
Unrealized gain on investments		(768,000)
Loss on disposal of plant and equipment		251,291
Deferred income taxes	58,268	52,518
Other non-cash items	(870)	(19,631)
Changes in assets and liabilities:
Accounts receivable	(113,412)	(2,144,699)
Contract assets	(1,588,176)	1,867,058
Inventory	(896,783)	(1,309,827)
Prepaid expenses and other current assets	15,507	418,317
Accounts payable and accrued expenses	(1,441,710)	304,955
Billings in excess of revenue earned	885,641	1,070,129
Net cash used in operating activities	(6,759,305)	(11,378,780)
Cash flows from investing activities:
Other assets	266,972	(100,810)
Capital expenditures	(206,127)	(119,815)
Proceeds from sale of marketable debt securities	9,296,550	3,789,139
Cash paid for equity investment		(2,500,000)
Net cash provided by investing activities	9,357,395	1,068,514
Cash flows from financing activities:
Paycheck protection program loan receipt	2,238,000
Paycheck protection program loan repayment	(2,070,000)
Sale of registered stock		8,128,531
Settlements of restricted stock for tax withholding obligations		(7,128)
Net cash provided by (used in) financing activities	168,000	8,121,403
Effect of exchange rate changes on cash	(18,517)	(2,958)
Net increase (decrease) in cash and cash equivalents	2,747,573	(2,191,821)
Cash and cash equivalents:
Beginning of period	6,029,247	14,326,347
End of period	8,776,820	12,134,526
Supplemental disclosure of cash flow information:
Issuance costs included in accounts payable and accrued expenses		90,000
Cash paid for interest	$ 1,495

BASIS OF PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Jun. 27, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting [Text Block]	1. BASIS OF PRESENTATION The condensed consolidated financial statements of Kopin Corporation as of June 27, 2020 and for the three and six month periods ended June 27, 2020 and June 29, 2019 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2019. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. The Company reclassified certain prior period amounts to conform to the current period presentation. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred net losses of $ 29.4 million and net cash outflows from operations of $ 21.0 million for the fiscal year ended 2019. The Company incurred a net loss of $ 4.8 million and net cash outflows from operations of $ 6.8 million for the six months ended June 27, 2020. In addition, the Company has experienced a significant decline in its cash and cash equivalents and marketable debt securities over the last several years, which was primarily a result of funding operating losses, of which a significant component related to the Company’s ongoing investments in the research and development of Wearable products. The Company had $ 15.3 million of cash and cash equivalents and marketable debt securities at June 27, 2020. The Company’s historical and current use of cash in operations combined with limited liquidity resources raise substantial doubt regarding the Company’s ability to continue as a going concern. The Company’s products are targeted towards the military and industrial wearable markets. Management believes the industrial wearable market is still developing and cannot predict how long it will take to develop or if the Company’s products will be accepted. In addition, the Company’s current strategy is to continue to invest in research and development, even during unprofitable periods, which may result in the Company continuing to incur net losses and negative cash flows from operations. If the Company is unable to achieve and maintain positive cash flows and profitability in the foreseeable future, its financial condition may ultimately be materially adversely affected such that management may be required to reduce operating expenses, including investments in research and development, or raise additional capital. While there can be no assurance the Company will be able to successfully reduce operating expenses or raise additional capital, management believes its historical success in managing cash flows and obtaining capital will continue in the foreseeable future. In March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic has negatively impacted the global and national economy, disrupted global supply chains, and created significant volatility in and disruption of financial markets. The extent of the impact of the COVID-19 pandemic on the Company’s operational and financial performance, including the ability to execute business strategies and initiatives in the expected time frame, will depend on future developments, including the duration and spread of the pandemic and related restrictions on travel and transportation, all of which are uncertain and cannot be predicted at this time. An extended period of global supply chain and economic disruption could materially affect Kopin’s business, results of operations, financial condition, and access to sources of liquidity. In this regard, the CARES Act established a Paycheck Protection Program, whereby certain small businesses are eligible for a loan to fund payroll expenses, rent, and related costs. During the second quarter ended June 27, 2020 the Company and a subsidiary each received a loan under the PPP. In May, 2020, the Company voluntarily terminated its PPP Loan and repaid the PPP Loan of $ 2.1 million and the Company’s subsidiary repaid its PPP loan of $ 0.1 million in July, 2020. The Company’s decision to terminate the loans was based on additional guidance issued by the Small Business Administration. There were no prepayment penalties in connection with the voluntary terminations.

ACCOUNTING STANDARDS

ACCOUNTING STANDARDS	6 Months Ended
	Jun. 27, 2020
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2. ACCOUNTING STANDARDS Accounting Standards Issued But Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments

CASH AND CASH EQUIVALENTS AND M

CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES	6 Months Ended
	Jun. 27, 2020
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Marketable Securities [Text Block]	3. CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents. Marketable debt securities consist primarily of commercial paper, medium-term corporate notes, and U.S. government and agency backed securities. The Company classifies these marketable debt securities as available-for-sale at fair value in “Marketable debt securities, at fair value.” The Company records the amortization of premium and accretion of discounts on marketable debt securities in the results of operations. The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable debt securities. The gross gains and losses realized related to sales and maturities of marketable debt securities were not material during the three and six months ended June 27, 2020 and June 29, 2019. Investments in available-for-sale marketable debt securities were as follows at June 27, 2020 and December 28, 2019: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Gains Unrealized Losses Fair Value 2020 2019 2020 2019 2020 2019 2020 2019 U.S. government and agency backed securities $ 1,005,819 $ 8,304,229 $ 27,521 $ - $ - $ (7,359) $ 1,033,340 $ 8,296,870 Corporate Debt 5,456,757 7,459,298 - - (4,401) (3,171) 5,452,356 7,456,127 Total $ 6,462,576 $ 15,763,527 $ 27,521 $ - $ (4,401) $ (10,530) $ 6,485,696 $ 15,752,997 The contractual maturity of the Company’s marketable debt securities was as follows at June 27, 2020: SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One year One to Five years Total U.S. government and agency backed securities $ - 1,033,340 1,033,340 Corporate debt 1,552,336 3,900,020 5,452,356 Total $ 1,552,336 4,933,360 6,485,696

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Jun. 27, 2020
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	4. FAIR VALUE MEASUREMENTS Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates, yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets. The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS Fair Value Measurement June 27, 2020 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 8,776,820 $ 8,776,820 $ - $ - U.S. Government Securities 1,033,340 - 1,033,340 - Corporate Debt 5,452,356 - 5,452,356 - Equity Investments 4,222,896 299,998 - 3,922,898 $ 19,485,412 $ 9,076,818 $ 6,485,696 $ 3,922,898 Fair Value Measurement at Dec 28, 2019 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 6,029,247 $ 6,029,247 $ - $ - U.S. Government Securities 8,296,870 - 8,296,870 - Corporate Debt 7,456,127 - 7,456,127 - Equity Investments 4,537,159 386,711 - 4,150,448 $ 26,319,403 $ 6,415,958 $ 15,752,997 $ 4,150,448 Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows: SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION December 28, 2019 Net unrealized losses Purchases, issuances and settlements Transfers in and or out of Level 3 June 27, 2020 Equity Investments $ 4,150,448 $ (227,550) $ $ $ 3,922,898 The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature. If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy. Marketable Debt Securities The corporate debt consists of floating rate notes with a maturity that is over multiple years but has interest rates that are reset every three months based on the then-current three-month London Interbank Offering Rate (“three-month Libor”). The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model that incorporates the three-month Libor, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets. Equity Investments The Company acquired an equity interest in a company in the first quarter of 2018 through a $ 1.0 0.1 11 3.5 In 2017 the Company had a warrant to acquire up to 15 2.0 0.1 2.5 0.8 5.2 On September 30, 2019 the Company entered into an Asset Purchase Agreement (the “Solos Purchase Agreement”) pursuant to which the Company sold and licensed certain assets of our Solos TM TM 20 0.2

INVENTORY

INVENTORY	6 Months Ended
	Jun. 27, 2020
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	5. INVENTORY Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at June 27, 2020 and December 28, 2019: SCHEDULE OF INVENTORY June 27, 2020 December 28, 2019 Raw materials $ 2,598,727 $ 2,630,156 Work-in-process 544,528 711,475 Finished goods 568,792 427,065 Total $ 3,712,047 $ 3,768,696

NET LOSS PER SHARE

NET LOSS PER SHARE	6 Months Ended
	Jun. 27, 2020
Net loss per share
Earnings Per Share [Text Block]	6. NET LOSS PER SHARE Basic net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period less any unvested restricted shares. Diluted net loss per share is calculated using weighted-average shares outstanding and contingently issuable shares, less weighted-average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of unvested restricted stock. The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period: SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Non-vested restricted common stock 2,373,874 2,047,374 2,373,874 2,047,374

STOCKHOLDERS_ EQUITY AND STOCK-

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	6 Months Ended
	Jun. 27, 2020
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement [Text Block]	7. STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION Restricted Stock Awards In May of 2020, the Company adopted a 2020 Equity Incentive Plan (“2020 Equity Plan”) which authorized the issuance of shares of common stock to employees, non-employees, and the Board. The 2020 Equity Plan was a successor to the Company’s 2010 Equity Incentive Plan (“2010 Equity Plan”). The number of shares authorized to be issued under the 2020 Equity Plan is four million shares plus shares of the Company Stock underlying any outstanding award granted under the 2010 Equity Plan that expires, or is terminated, surrendered or forfeited for any reason without issuance of such shares. Registered sale of equity securities On March 15, 2019, the Company sold 7.3 8.0 1.10 0.7 8.9 0.7 0.8 1.10 0.1 0.8 Non-Vested Restricted Common Stock The fair value of non-vested restricted common stock awards is generally the market value of the Company’s common stock on the date of grant. The non-vested restricted common stock awards require the employee to fulfill certain obligations, including remaining employed by the Company for one, two or four years (the vesting period) and in certain cases also require meeting either performance criteria or the Company’s stock achieving a certain price. For non-vested restricted common stock awards that solely require the recipient to remain employed with the Company, the stock compensation expense is amortized over the anticipated service period. For non-vested restricted common stock awards that require the achievement of performance criteria, the Company reviews the probability of achieving the performance goals on a periodic basis. If the Company determines that it is probable that the performance criteria will be achieved, the amount of compensation cost derived for the performance goal is amortized over the anticipated service period. If the performance criteria are not met, no compensation cost is recognized and any previously recognized compensation cost is reversed. Restricted stock activity was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Weighted Average Shares Grant Fair Value Balance, December 28, 2019 1,863,124 $ 1.60 Granted 593,000 0.47 Forfeited (22,250) 2.07 Vested (60,000) 1.12 Balance, June 27, 2020 2,373,874 $ 1.32 On December 31, 2017, the Company amended the employment agreement with our CEO, Dr. John Fan, to expire on December 31, 2020 and as part of the amendment issued restricted stock grants. Of the restricted stock grants issued to Dr. Fan, 640,000 150,000 150,000 December 31, 2020 1.7 SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS For the three months ended For the three months ended For the three months ended June 27, 2020 June 27, 2020 June 27, 2020 Performance price target $ 5.25 $ 6.00 $ 7.00 Expected volatility 48.3% 48.3% 48.3% Interest rate 1.97% 1.97% 1.97% Expected Life (years) 3 3 3 Dividend yield —% —% —% Stock-Based Compensation The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and six months ended June 27, 2020 and June 29, 2019 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Cost of product revenues $ 16,269 $ 32,107 $ 30,246 $ 64,215 Research and development 57,523 83,785 112,655 188,515 Selling, general and administrative 87,885 422,582 177,241 1,101,586 Total $ 161,677 $ 538,474 $ 320,142 $ 1,354,316 Unrecognized compensation expense for non-vested restricted common stock as of June 27, 2020 totaled $ 0.7 two years

ACCRUED WARRANTY

ACCRUED WARRANTY	6 Months Ended
	Jun. 27, 2020
Guarantees and Product Warranties [Abstract]
Product Warranty Disclosure [Text Block]	8. ACCRUED WARRANTY The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty. SCHEDULE OF ACCRUED WARRANTY Balance, December 28, 2019 $ 509,000 Additions 348,000 Claims (349,000) Balance, June 27, 2020 $ 508,000 Extended Warranties Deferred revenue represents the purchase of extended warranties by the Company’s customers. The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months standard 12 to 18 month warranty. 0.1

INCOME TAXES

INCOME TAXES	6 Months Ended
	Jun. 27, 2020
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	9. INCOME TAXES The Company recorded a provision for income taxes of less than $ 0.1 million in the three and six months ended June 27, 2020 and June 29, 2019, respectively. As of June 27, 2020, the Company has available for tax purposes U.S. federal NOLs of approximately $ 160.5 million expiring 2022 through 2037 and $ 59.1 million that have an unlimited carryover period. The Company had recognized a full valuation allowance on its domestic and certain foreign net deferred tax assets due to the uncertainty of realization of such assets. The Company recognizes both accrued interest and penalties related to its uncertain tax positions related to intercompany loan interest and potential transfer pricing exposure related to its foreign subsidiaries.

CONTRACT ASSETS AND LIABILITIES

CONTRACT ASSETS AND LIABILITIES	6 Months Ended
	Jun. 27, 2020
Contract Assets And Liabilities
CONTRACT ASSETS AND LIABILITIES	10. CONTRACT ASSETS AND LIABILITIES Contract assets include unbilled amounts typically resulting from sales under contracts when the cost-to-cost method of revenue recognition is utilized and revenue recognized from customer arrangements, including licensing, exceeds the amount billed to the customer, and right to payment is not just subject to the passage of time. Amounts may not exceed their net realizable value. Contract assets are generally classified as current. The Company classifies the noncurrent portion of contract assets under other assets in its condensed consolidated balance sheets. Contract liabilities consist of advance payments and billings in excess of cost incurred and deferred revenue. Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY June 27, 2020 December 28, 2019 $ Change % Change Contract assets ---current 2,509,258 $ 921,082 $ 1,588,176 172 Contract liabilities---current (1,687,403) $ (796,794 $ (890,609) 112% Contract liabilities---noncurrent (1,589) $ (6,557) $ 4,968 (76)% Net contract assets (liabilities) $ 820,266 $ 117,731 $ 702,535 597% The $0.7 increase in the Company’s net contract assets at June 27, 2020 as compared to December 28, 2019 was primarily due to an increase in inventory and other costs associated with government contracts which recognize revenue over time, which was partially offset by an increase in billing in excess of revenue earned. In the three and six months ended June 27, 2020, the Company recognized revenue of $ 0.6 million, related to our contract liabilities at December 28, 2019. In the three and six months ended June 29, 2019, the Company recognized revenue of $ 0.1 million and $0.3 million, respectively, related to our contract liabilities at December 29, 2018. The Company did not Performance Obligations The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS Three months ended Three months ended Six months ended Six months ended June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Point in time 39 % 78% 37 % 75% Over time 61 % 22% 63 % 25% Remaining performance obligations represent the transaction price of orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts (e.g., indefinite-delivery, indefinite-quantity (“IDIQ”)). As of June 27, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations was $5.7 million which the Company expects to recognize over the next 12 months. The remaining performance obligations represent amounts to be earned under government contracts, which are subject to cancellation.

LEASES

LEASES	6 Months Ended
	Jun. 27, 2020
Leases [Abstract]
Leases of Lessee Disclosure [Text Block]	11. LEASES The Company enters into operating leases primarily for: real estate, including for manufacturing, engineering, research, administration and sales facilities, and information technology (“IT”) equipment. At June 27, 2020 and December 28, 2019, the Company did not have any finance leases. Approximately all of our future lease commitments, and related lease liability, relate to the Company’s real estate leases. Some of the Company’s leases include options to extend or terminate the lease. The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 27,2020 June 29, 2019 June 27, 2020 June 29, 2019 Operating lease cost $ 283,443 $ 308,080 $ 566,443 $ 603,565 At June 27, 2020, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2020 (excluding the six months ended June 27, 2020) $ 596,627 2021 1,048,973 2022 653,367 2023 201,333 Thereafter - Total future lease payments $ 2,500,300 Less imputed interest (187,955) Total $ 2,312,345 The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheets at June 27, 2020 was as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS June 27, 2020 Operating lease liabilities - current $ 1,077,756 Operating lease liabilities -noncurrent 1,236,818 Total lease liabilities $ 2,314,574 Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Six months ended June 27, 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 591,500 Other information related to leases was as follows: June 27, 2020 Weighted Average Discount Rate - Operating Leases 6.16% Weighted Average Remaining Lease Term - Operating Leases (in years) 2.39

SEGMENTS AND DISAGGREGATION OF

SEGMENTS AND DISAGGREGATION OF REVENUE	6 Months Ended
	Jun. 27, 2020
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	12. SEGMENTS AND DISAGGREGATION OF REVENUE We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine if any changes have occurred that would affect our reportable segments. In the fourth quarter of 2019, as a result of the changes in our operations and management structure we commenced reporting under one segment. We have retrospectively adjusted our segment disclosures to present one reportable segment , as our Chief Executive Officer, who is our chief operating decision maker (“CODM”), reviews results on a total company basis. Total long-lived assets by country at June 27, 2020 and December 28, 2019 were: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) June 27, 2020 December 28, 2019 U.S. $ 3,144 $ 3,647 United Kingdom 352 442 China 23 37 Japan 70 101 Total $ 3,589 $ 4,227 We disaggregate our revenue from contracts with customers by geographic location and by display application, as we believe it best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. During the three and six months ended June 27, 2020 and June 29, 2019, the Company derived its sales from the following geographies: SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE Three months ended Three months ended Six months Six months June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 (In thousands) Revenue % of Total Revenue % of Total Revenue % of Total Revenue % of Total United States $ 6,938 79% $ 2,605 29% $ 13,704 82% $ 5,011 35% Other Americas - - 7 - 101 1 25 - Total Americas 6,938 79 2,612 29 13,805 83 5,036 35 Asia - Pacific 1,642 18 5,817 64 2,306 14 7,690 52 Europe 235 3 671 7 582 3 1,917 13 Other - - 10 - - - 10 - Total Revenues $ 8,815 100% $ 9,110 100% $ 16,693 100% $ 14,653 100% During the three and six months ended June 27, 2020 and June 29, 2019, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT Three months ended Three months ended Six months ended Six months ended (In thousands) June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Military $ 4,490 $ 1,797 $ 8,003 $ 3,238 Industrial 1,396 2,135 3,579 4,638 Consumer 232 503 453 1,149 R&D 1,772 455 3,733 1,199 License, royalties and other 925 4,220 925 4,429 Total Revenues $ 8,815 $ 9,110 $ 16,693 $ 14,653

LITIGATION

LITIGATION	6 Months Ended
	Jun. 27, 2020
Commitments and Contingencies Disclosure [Abstract]
Legal Matters and Contingencies [Text Block]	13. LITIGATION The Company may engage in legal proceedings arising in the ordinary course of business. Claims, suits, investigations and proceedings are inherently uncertain and it is not possible to predict the ultimate outcome of such matters and our business, financial condition, results of operations or cash flows could be affected in any particular period. BlueRadios, Inc. v. Kopin Corporation, Civil Action No. 16-02052-JLK (D. Col.): On August 12, 2016, BlueRadios, Inc. (“BlueRadios”) filed a complaint in the U.S. District Court for the District of Colorado, alleging that the Company breached a contract between it and BlueRadios concerning an alleged joint venture between the Company and BlueRadios to design, develop and commercialize micro-display products with embedded wireless technology referred to as “Golden-i” breached the covenant of good faith and fair dealing associated with that contract, breached its fiduciary duty to BlueRadios, and misappropriated trade secrets owned by BlueRadios in violation of Colorado law (C.R.S. § 7-74-104(4)) and the Defend Trade Secrets Act (18 U.S.C. § 1836(b)(1)). BlueRadios further alleges that the Company was unjustly enriched by its alleged misconduct, BlueRadios is entitled to an accounting to determine the amount of profits obtained by the Company as a result of its alleged misconduct, and the inventorship on at least ten patents or patent applications owned by the Company need to be corrected to list BlueRadios’ employees as inventors and thereby list BlueRadios as co-assignees of the patents. BlueRadios seeks monetary, declaratory, and injunctive relief, including for alleged non-payment of engineering retainer fees. On October 11, 2016, the Company filed its Answer and Affirmative Defenses. The parties completed expert depositions on November 15, 2019. On December 2, 2019, the Company filed a Motion for Partial Summary Judgment requesting the Court dismiss counts 2-7 in their entirety and counts 1 and 8 in part. BlueRadios also filed a Motion for Partial Summary Judgment alleging it is the co-owner of U.S. Patent No. 8,909,296. Responses to the Motions for Partial Summary Judgment were filed on January 15, 2020, and replies were filed on February 19, 2020. A trial date has not yet been set by the Court. The Company has not concluded a loss from this matter is probable; therefore, we have not recorded an accrual for litigation or claims related to this matter for the period ended June 27, 2020. The Company will continue to evaluate information as it becomes known and will record an estimate for losses at the time or times when it is both probable that a loss has been incurred and the amount of the loss is reasonably estimable.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 27, 2020
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	14. RELATED PARTY TRANSACTIONS The Company may from time to time enter into agreements with stockholders, affiliates and other companies engaged in certain aspects of the display, electronics, optical and software industries as part of our business strategy. In addition, the wearable computing product market is relatively new and there may be other technologies the Company needs to purchase from affiliates to enhance its product offering. During the three and six months ended June 27, 2020 and June 29, 2019, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three Months Ended June 27, 2020 June 29, 2019 Sales Purchases Sales Purchases Solos Technology $ 106,390 $ — $ — $ — RealWear, Inc. 371,902 — 4,667,258 — $ 478,292 $ — $ 4,667,258 $ — Six Months Ended June 27, 2020 June 29, 2019 Sales Purchases Sales Purchases Goertek $ — $ — $ — $ 1,246,077 Solos Technology 246,458 — — — RealWear, Inc. 371,902 — 5,192,644 — $ 618,360 $ — $ 5,192,644 $ 1,246,077 At June 27, 2020 and December 28, 2019, the Company had the following receivables, contract liabilities and payables with related parties: June 27, 2020 December 28, 2019 Receivables Contract Liabilities Payables Receivables Contract Assets Payables Solos Technology $ 79,146 $ — $ 15,015 $ 283,203 — — RealWear, Inc. 363,607 395,386 — 646,848 — — $ 442,753 $ 395,386 $ 15,015 $ 930,051 $ — $ —

CASH AND CASH EQUIVALENTS AND_2

CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES (Tables)	6 Months Ended
	Jun. 27, 2020
Cash and Cash Equivalents [Abstract]
SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES	Investments in available-for-sale marketable debt securities were as follows at June 27, 2020 and December 28, 2019: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Gains Unrealized Losses Fair Value 2020 2019 2020 2019 2020 2019 2020 2019 U.S. government and agency backed securities $ 1,005,819 $ 8,304,229 $ 27,521 $ - $ - $ (7,359) $ 1,033,340 $ 8,296,870 Corporate Debt 5,456,757 7,459,298 - - (4,401) (3,171) 5,452,356 7,456,127 Total $ 6,462,576 $ 15,763,527 $ 27,521 $ - $ (4,401) $ (10,530) $ 6,485,696 $ 15,752,997
SCHEDULE OF MARKETABLE DEBT SECURITIES	The contractual maturity of the Company’s marketable debt securities was as follows at June 27, 2020: SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One year One to Five years Total U.S. government and agency backed securities $ - 1,033,340 1,033,340 Corporate debt 1,552,336 3,900,020 5,452,356 Total $ 1,552,336 4,933,360 6,485,696

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Jun. 27, 2020
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS	The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS Fair Value Measurement June 27, 2020 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 8,776,820 $ 8,776,820 $ - $ - U.S. Government Securities 1,033,340 - 1,033,340 - Corporate Debt 5,452,356 - 5,452,356 - Equity Investments 4,222,896 299,998 - 3,922,898 $ 19,485,412 $ 9,076,818 $ 6,485,696 $ 3,922,898 Fair Value Measurement at Dec 28, 2019 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 6,029,247 $ 6,029,247 $ - $ - U.S. Government Securities 8,296,870 - 8,296,870 - Corporate Debt 7,456,127 - 7,456,127 - Equity Investments 4,537,159 386,711 - 4,150,448 $ 26,319,403 $ 6,415,958 $ 15,752,997 $ 4,150,448
SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION	Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows: SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION December 28, 2019 Net unrealized losses Purchases, issuances and settlements Transfers in and or out of Level 3 June 27, 2020 Equity Investments $ 4,150,448 $ (227,550) $ $ $ 3,922,898

INVENTORY (Tables)

INVENTORY (Tables)	6 Months Ended
	Jun. 27, 2020
Inventory Disclosure [Abstract]
SCHEDULE OF INVENTORY	Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at June 27, 2020 and December 28, 2019: SCHEDULE OF INVENTORY June 27, 2020 December 28, 2019 Raw materials $ 2,598,727 $ 2,630,156 Work-in-process 544,528 711,475 Finished goods 568,792 427,065 Total $ 3,712,047 $ 3,768,696

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)	6 Months Ended
	Jun. 27, 2020
Net loss per share
SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED	The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period: SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Non-vested restricted common stock 2,373,874 2,047,374 2,373,874 2,047,374

STOCKHOLDERS_ EQUITY AND STOC_2

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)	6 Months Ended
	Jun. 27, 2020
Share-based Payment Arrangement [Abstract]
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY	Restricted stock activity was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Weighted Average Shares Grant Fair Value Balance, December 28, 2019 1,863,124 $ 1.60 Granted 593,000 0.47 Forfeited (22,250) 2.07 Vested (60,000) 1.12 Balance, June 27, 2020 2,373,874 $ 1.32
SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS	SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS For the three months ended For the three months ended For the three months ended June 27, 2020 June 27, 2020 June 27, 2020 Performance price target $ 5.25 $ 6.00 $ 7.00 Expected volatility 48.3% 48.3% 48.3% Interest rate 1.97% 1.97% 1.97% Expected Life (years) 3 3 3 Dividend yield —% —% —%
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE	The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and six months ended June 27, 2020 and June 29, 2019 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Cost of product revenues $ 16,269 $ 32,107 $ 30,246 $ 64,215 Research and development 57,523 83,785 112,655 188,515 Selling, general and administrative 87,885 422,582 177,241 1,101,586 Total $ 161,677 $ 538,474 $ 320,142 $ 1,354,316

ACCRUED WARRANTY (Tables)

ACCRUED WARRANTY (Tables)	6 Months Ended
	Jun. 27, 2020
Guarantees and Product Warranties [Abstract]
SCHEDULE OF ACCRUED WARRANTY	SCHEDULE OF ACCRUED WARRANTY Balance, December 28, 2019 $ 509,000 Additions 348,000 Claims (349,000) Balance, June 27, 2020 $ 508,000

CONTRACT ASSETS AND LIABILITI_2

CONTRACT ASSETS AND LIABILITIES (Tables)	6 Months Ended
	Jun. 27, 2020
Contract Assets And Liabilities
SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY	Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY June 27, 2020 December 28, 2019 $ Change % Change Contract assets ---current 2,509,258 $ 921,082 $ 1,588,176 172 Contract liabilities---current (1,687,403) $ (796,794 $ (890,609) 112% Contract liabilities---noncurrent (1,589) $ (6,557) $ 4,968 (76)% Net contract assets (liabilities) $ 820,266 $ 117,731 $ 702,535 597%
SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS	The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS Three months ended Three months ended Six months ended Six months ended June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Point in time 39 % 78% 37 % 75% Over time 61 % 22% 63 % 25%

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Jun. 27, 2020
Leases [Abstract]
SCHEDULE OF LEASE EXPENSE	The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 27,2020 June 29, 2019 June 27, 2020 June 29, 2019 Operating lease cost $ 283,443 $ 308,080 $ 566,443 $ 603,565
SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE	At June 27, 2020, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2020 (excluding the six months ended June 27, 2020) $ 596,627 2021 1,048,973 2022 653,367 2023 201,333 Thereafter - Total future lease payments $ 2,500,300 Less imputed interest (187,955) Total $ 2,312,345
SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS	The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheets at June 27, 2020 was as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS June 27, 2020 Operating lease liabilities - current $ 1,077,756 Operating lease liabilities -noncurrent 1,236,818 Total lease liabilities $ 2,314,574
SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES	Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Six months ended June 27, 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 591,500 Other information related to leases was as follows: June 27, 2020 Weighted Average Discount Rate - Operating Leases 6.16% Weighted Average Remaining Lease Term - Operating Leases (in years) 2.39

SEGMENTS AND DISAGGREGATION O_2

SEGMENTS AND DISAGGREGATION OF REVENUE (Tables)	6 Months Ended
	Jun. 27, 2020
Segment Reporting [Abstract]
SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS	Total long-lived assets by country at June 27, 2020 and December 28, 2019 were: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) June 27, 2020 December 28, 2019 U.S. $ 3,144 $ 3,647 United Kingdom 352 442 China 23 37 Japan 70 101 Total $ 3,589 $ 4,227
SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE	During the three and six months ended June 27, 2020 and June 29, 2019, the Company derived its sales from the following geographies: SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE Three months ended Three months ended Six months Six months June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 (In thousands) Revenue % of Total Revenue % of Total Revenue % of Total Revenue % of Total United States $ 6,938 79% $ 2,605 29% $ 13,704 82% $ 5,011 35% Other Americas - - 7 - 101 1 25 - Total Americas 6,938 79 2,612 29 13,805 83 5,036 35 Asia - Pacific 1,642 18 5,817 64 2,306 14 7,690 52 Europe 235 3 671 7 582 3 1,917 13 Other - - 10 - - - 10 - Total Revenues $ 8,815 100% $ 9,110 100% $ 16,693 100% $ 14,653 100%
SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT	During the three and six months ended June 27, 2020 and June 29, 2019, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT Three months ended Three months ended Six months ended Six months ended (In thousands) June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Military $ 4,490 $ 1,797 $ 8,003 $ 3,238 Industrial 1,396 2,135 3,579 4,638 Consumer 232 503 453 1,149 R&D 1,772 455 3,733 1,199 License, royalties and other 925 4,220 925 4,429 Total Revenues $ 8,815 $ 9,110 $ 16,693 $ 14,653

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	6 Months Ended
	Jun. 27, 2020
Related Party Transactions [Abstract]
SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES	During the three and six months ended June 27, 2020 and June 29, 2019, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three Months Ended June 27, 2020 June 29, 2019 Sales Purchases Sales Purchases Solos Technology $ 106,390 $ — $ — $ — RealWear, Inc. 371,902 — 4,667,258 — $ 478,292 $ — $ 4,667,258 $ — Six Months Ended June 27, 2020 June 29, 2019 Sales Purchases Sales Purchases Goertek $ — $ — $ — $ 1,246,077 Solos Technology 246,458 — — — RealWear, Inc. 371,902 — 5,192,644 — $ 618,360 $ — $ 5,192,644 $ 1,246,077 At June 27, 2020 and December 28, 2019, the Company had the following receivables, contract liabilities and payables with related parties: June 27, 2020 December 28, 2019 Receivables Contract Liabilities Payables Receivables Contract Assets Payables Solos Technology $ 79,146 $ — $ 15,015 $ 283,203 — — RealWear, Inc. 363,607 395,386 — 646,848 — — $ 442,753 $ 395,386 $ 15,015 $ 930,051 $ — $ —

BASIS OF PRESENTATION (Details

BASIS OF PRESENTATION (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2020	May 31, 2020	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019	Dec. 28, 2019
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss) Attributable to Parent			$ (1,121,541)	$ (4,260,391)	$ (4,717,060)	$ (15,591,318)
Net cash outflows from operations					6,800,000
Net Income (Loss) Attributable to Parent					4,800,000
Cash and cash equivalents and marketable debt securities			$ 15,300,000		$ 15,300,000
Paycheck Protection Program Loan [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Early Repayment of Subordinated Debt		$ 2,100,000
Paycheck Protection Program Loan [Member] | Subsidiaries [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Early Repayment of Subordinated Debt	$ 100,000
Fiscal Period Twenty Ninteen [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss) Attributable to Parent							$ 29,400,000
Net cash outflows from operations							$ 21,000,000

SCHEDULE OF AVAILABLE-FOR-SALE

SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES (Details) - USD ($)	Jun. 27, 2020	Dec. 28, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	$ 6,462,576	$ 15,763,527
Unrealized Gains	27,521
Unrealized Losses	(4,401)	(10,530)
Fair Value	6,485,696	15,752,997
U S Government And Agency Backed Securities [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	1,005,819	8,304,229
Unrealized Gains	27,521
Unrealized Losses		(7,359)
Fair Value	1,033,340	8,296,870
Corporate Debt [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	5,456,757	7,459,298
Unrealized Gains
Unrealized Losses	(4,401)	(3,171)
Fair Value	$ 5,452,356	$ 7,456,127

SCHEDULE OF MARKETABLE DEBT SEC

SCHEDULE OF MARKETABLE DEBT SECURITIES (Details)	Jun. 27, 2020USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year	$ 1,552,336
One to Five years	4,933,360
Total	6,485,696
U S Government And Agency Backed Securities [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year
One to Five years	1,033,340
Total	1,033,340
Corporate Debt [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year	1,552,336
One to Five years	3,900,020
Total	$ 5,452,356

SCHEDULE OF FAIR VALUE MEASUREM

SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS (Details) - USD ($)	Jun. 27, 2020	Dec. 28, 2019
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	$ 19,485,412	$ 26,319,403
Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	9,076,818	6,415,958
Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	6,485,696	15,752,997
Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	3,922,898	4,150,448
Cash and Cash Equivalents [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	8,776,820	6,029,247
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	8,776,820	6,029,247
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
U.S. Government Securities [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	1,033,340	8,296,870
U.S. Government Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
U.S. Government Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	1,033,340	8,296,870
U.S. Government Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Corporate Debt [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	5,452,356	7,456,127
Corporate Debt [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Corporate Debt [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	5,452,356	7,456,127
Corporate Debt [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Equity Investments [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	4,222,896	4,537,159
Equity Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	299,998	386,711
Equity Investments [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Equity Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	$ 3,922,898	$ 4,150,448

SCHEDULE OF FAIR VALUE, ASSETS

SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION (Details) - Equity Investments [Member]	6 Months Ended
	Jun. 27, 2020USD ($)
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial instrument fair value, beginnning	$ 4,150,448
Net unrealized losses	(227,550)
Purchases, issuances and settlements
Transfers in and or out of Level 3
Financial instrument fair value, ending	$ 3,922,898

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)	3 Months Ended					6 Months Ended		12 Months Ended
	Jun. 27, 2020	Dec. 28, 2019	Jun. 29, 2019	Jun. 30, 2018	Mar. 31, 2018	Jun. 27, 2020	Jun. 29, 2019	Dec. 30, 2017	Sep. 30, 2019	May 31, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Payments to acquire equity investment					$ 1,000,000		$ 2,500,000
Unrealized Gain (Loss) on Securities	$ 100,000		$ 800,000			$ 100,000
Ownership percentage interest	11.00%					11.00%
Equity Method Investments, Fair Value Disclosure	$ 3,500,000					$ 3,500,000
Impairment of equity security		$ 5,200,000
Solos Inc [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Ownership percentage interest									20.00%
Series A Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Gain on fair value of warrant								$ 2,000,000
Loss on warrant				$ 100,000
Series B [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity Securities, FV-NI										$ 2,500,000
Maximum [Member] | Solos Inc [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Impairment on investment	$ 200,000					$ 200,000
Warrant [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Ownership percentage in equity investment warrant								15.00%

SCHEDULE OF INVENTORY (Details)

SCHEDULE OF INVENTORY (Details) - USD ($)	Jun. 27, 2020	Dec. 28, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 2,598,727	$ 2,630,156
Work-in-process	544,528	711,475
Finished goods	568,792	427,065
Total	$ 3,712,047	$ 3,768,696

SCHEDULE OF WEIGHTED-AVERAGE CO

SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Net loss per share
Non-vested restricted common stock	2,373,874	2,047,374	2,373,874	2,047,374

SCHEDULE OF NON-VESTED RESTRICT

SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY (Details)	6 Months Ended
	Jun. 27, 2020$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of Shares, Restricted stock Outstanding Beginning | shares	1,863,124
Weighted Average Grant Date Fair Value, Restricted stock Outstanding Beginning | $ / shares	$ 1.60
Number of Shares, Restricted stock Granted | shares	593,000
Weighted Average Grant Date Fair Value, Restricted stock Granted | $ / shares	$ 0.47
Number of Shares, Restricted stock Forfeited | shares	(22,250)
Weighted Average Grant Date Fair Value, Restricted stock Forfeited | $ / shares	$ 2.07
Number of Shares, Restricted stock Vested | shares	(60,000)
Weighted Average Grant Date Fair Value, Restricted stock Vested | $ / shares	$ 1.12
Number of Shares, Restricted stock Outstanding Ending | shares	2,373,874
Weighted Average Grant Date Fair Value, Restricted stock Outstanding Ending | $ / shares	$ 1.32

SCHEDULE OF SHARE-BASED PAYMENT

SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS (Details)	3 Months Ended
	Jun. 27, 2020$ / shares
Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 5.25
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield	0.00%
Share-based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 6
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield	0.00%
Share-based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 7
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield	0.00%

SCHEDULE OF STOCK-BASED COMPENS

SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	$ 161,677	$ 538,474	$ 320,142	$ 1,354,316
Cost of Product Revenues [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	16,269	32,107	30,246	64,215
Research and Development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	57,523	83,785	112,655	188,515
Selling, General and Administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	$ 87,885	$ 422,582	$ 177,241	$ 1,101,586

STOCKHOLDERS_ EQUITY AND STOC_3

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($) $ / shares in Units, $ in Millions	Apr. 10, 2019	Mar. 15, 2019	Dec. 31, 2017	Jun. 27, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of Stock, Number of Shares Issued in Transaction	700,000	7,300,000
Gross proceeds from registered sale of equity securities	$ 0.8	$ 8
Shares issued price per share	$ 1.10	$ 1.10
Underwriting discounts and offering expenses from sale of equity		$ 0.7
Percentage of common stock outstanding	0.80%	890.00%
Payments of Stock Issuance Costs	$ 0.1
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				593,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized				$ 0.7
Unrecognized compensation weighted average period				two years
Employment Agreement [Member] | Dr. John Fan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants expire date			Dec. 31, 2020
Total fair value awards			$ 1.7
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $5.25 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			640,000
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $6.00 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			150,000
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $7.00 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			150,000

SCHEDULE OF ACCRUED WARRANTY (D

SCHEDULE OF ACCRUED WARRANTY (Details)	6 Months Ended
	Jun. 27, 2020USD ($)
Guarantees and Product Warranties [Abstract]
Balance	$ 509,000
Additions	348,000
Claims	(349,000)
Balance	$ 508,000

ACCRUED WARRANTY (Details Narra

ACCRUED WARRANTY (Details Narrative) $ in Millions	6 Months Ended
	Jun. 27, 2020USD ($)
Revenue Benchmark [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Extended Product Warranty Description	The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months
Standard Product Warranty Description	standard 12 to 18 month warranty.
Warranty [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Product warranty term	The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty.
Deferred revenue	$ 0.1

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 27, 2020	Jun. 27, 2020	Jun. 29, 2019
Income Tax Disclosure [Abstract]
Current Income Tax Expense (Benefit)	$ 0.1		$ 0.1
Operating Loss Carryforwards	160.5	$ 160.5
Net operating loss expiry period		expiring 2022 through 2037
Operating loss carryforwards unlimited	$ 59.1	$ 59.1

SCHEDULE OF CONTRACT WITH CUSTO

SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY (Details) - USD ($)	Jun. 27, 2020	Dec. 28, 2019
Contract Assets And Liabilities
Contract assets-current	$ 2,509,258	$ 921,082
Change in contract assets-current	$ 1,588,176
Percentage of change in contract assets-current	172.00%
Contract liabilities-current	$ (1,687,403)	(796,794)
Change in contract liabilities current	$ (890,609)
Percentage of change in contract liabilities	112.00%
Contract liabilities-noncurrent	$ (1,589)	(6,557)
Change in contract liabilities-noncurrent	$ 4,968
Percentage of change in contract liabilities-noncurrent	(76.00%)
Net contract assets (liabilities)	$ 820,266	$ 117,731
Change in Net contract assets (liabilities	$ 702,535
Percentage of change in Net contract assets (liabilities)	597.00%

SCHEDULE OF SATISFACTION OF PER

SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS (Details)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Revenue percentage from products and services transferred customers	39.00%	78.00%	37.00%	75.00%
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Revenue percentage from products and services transferred customers	61.00%	22.00%	63.00%	25.00%

CONTRACT ASSETS AND LIABILITI_3

CONTRACT ASSETS AND LIABILITIES (Details Narrative) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Contract Assets And Liabilities
Increase in contract assets and liabilities		$ 0.7
Contract with Customer, Liability, Revenue Recognized	$ 0.1	0.6	$ 0.3
Revenue, Remaining Performance Obligation, Amount		$ 5.7

SCHEDULE OF LEASE EXPENSE (Deta

SCHEDULE OF LEASE EXPENSE (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Leases [Abstract]
Operating lease cost	$ 283,443	$ 308,080	$ 566,443	$ 603,565

SCHEDULE OF FUTURE LEASE PAYMEN

SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE (Details)	Jun. 27, 2020USD ($)
Leases [Abstract]
2020 (excluding the six months ended June 27, 2020)	$ 596,627
2021	1,048,973
2022	653,367
2023	201,333
Thereafter
Total future lease payments	2,500,300
Less imputed interest	(187,955)
Total	$ 2,312,345

SCHEDULE OF OPERATING LEASE PAY

SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS (Details) - USD ($)	Jun. 27, 2020	Dec. 28, 2019
Leases [Abstract]
Operating lease liabilities - current	$ 1,077,756	$ 1,041,695
Operating lease liabilities -noncurrent	1,236,818	$ 1,791,590
Total lease liabilities	$ 2,314,574

SCHEDULE OF SUPPLEMENTAL INFORM

SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)	6 Months Ended
	Jun. 27, 2020USD ($)
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 591,500
Weighted Average Discount Rate Operating Leases	6.16%
Weighted Average Remaining Lease Term Operating Leases (in years)	2 years 4 months 20 days

SCHEDULE OF LONG-LIVED ASSETS B

SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Dec. 28, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	$ 3,589	$ 4,227
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	3,144	3,647
UNITED KINGDOM
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	352	442
CHINA
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	23	37
JAPAN
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	$ 70	$ 101

SCHEDULE OF SEGMENT INFORMATION

SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 8,815	$ 9,110	$ 16,693	$ 14,653
Revenue percentage	100.00%	100.00%	100.00%	100.00%
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 6,938	$ 2,605	$ 13,704	$ 5,011
Revenue percentage	79.00%	29.00%	82.00%	35.00%
Other Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues		$ 7	$ 101	$ 25
Revenue percentage			1.00%
Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 6,938	$ 2,612	$ 13,805	$ 5,036
Revenue percentage	79.00%	29.00%	83.00%	35.00%
Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 1,642	$ 5,817	$ 2,306	$ 7,690
Revenue percentage	18.00%	64.00%	14.00%	52.00%
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 235	$ 671	$ 582	$ 1,917
Revenue percentage	3.00%	7.00%	3.00%	13.00%
Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues		$ 10		$ 10
Revenue percentage

SCHEDULE OF SEGMENT REPORTING I

SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Revenue from External Customer [Line Items]
Total Revenues	$ 8,815	$ 9,110	$ 16,693	$ 14,653
Military [Member]
Revenue from External Customer [Line Items]
Total Revenues	4,490	1,797	8,003	3,238
Industrial [Member]
Revenue from External Customer [Line Items]
Total Revenues	1,396	2,135	3,579	4,638
Consumer [Member]
Revenue from External Customer [Line Items]
Total Revenues	232	503	453	1,149
Research and Development [Member]
Revenue from External Customer [Line Items]
Total Revenues	1,772	455	3,733	1,199
License Royalties And Other [Member]
Revenue from External Customer [Line Items]
Total Revenues	$ 925	$ 4,220	$ 925	$ 4,429

SEGMENTS AND DISAGGREGATION O_3

SEGMENTS AND DISAGGREGATION OF REVENUE (Details Narrative)	6 Months Ended
	Jun. 27, 2020
Segment Reporting [Abstract]
Number of reportable segments	one reportable segment

SCHEDULE OF TRANSACTIONS WITH R

SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019	Dec. 28, 2019
Related Party Transaction [Line Items]
Sales	$ 478,292	$ 4,667,258	$ 618,360	$ 5,192,644
Purchases	0	0	0	1,246,077
Receivables	442,753		442,753		$ 930,051
Contract liabilities	395,386		395,386
Payables	15,015		15,015		0
Contract assets					0
Solos Technology [Member]
Related Party Transaction [Line Items]
Sales	106,390	0	246,458	0
Purchases	0	0	0	0
Receivables	79,146		79,146		283,203
Contract liabilities	0		0
Payables	15,015		15,015		0
Contract assets					0
RealWear, Inc. [Member]
Related Party Transaction [Line Items]
Sales	371,902	4,667,258	371,902	5,192,644
Purchases	0	$ 0	0	0
Receivables	363,607		363,607		646,848
Contract liabilities	395,386		395,386
Payables	$ 0		0		0
Contract assets					$ 0
Goertek [Member]
Related Party Transaction [Line Items]
Sales			0	0
Purchases			$ 0	$ 1,246,077